[Pharmacotherapeutic follow-up in hospitalised paediatric patients: adapting Dáder methodology].
OBJECTIVE
To adapt the DA inverted exclamation mark der methodology to identify and resolve drug related problems (DRP) in pediatric inpatients by disigning a normalized work procedure (NWP). To establish a pilot plan of pharmacotherapeutic follow-up to evaluate the NWP created.


METHODS
The DA inverted exclamation mark der methodology is taken as a base adapting it to the characteristics and needs of pediatric inpatients and a NWP for their pharmacotherapeutic follow-up is created. A pilot plan consisting in a prospective longitudinal follow-up study is designed. The population and setting of the study are all the inpatients during one month in a room at the Municipal Childrenâs Hospital.


RESULTS
The NWP is composed by the following steps: Previous phase: patient selection; follow-up phase: data compilation, information analysis (situation state, study phase, global evaluation), pharmaceutical intervention; results; clinical sessions; record documents. Pilot plan: 21 patients were studied; 71.4% of them presented at least 1 DRP during hospitalization period and 27 DRP were identified in all studied cases; 51.9% of DRP were effectiveness problems, 37.0% were related to safety and 11.1% to necessity; 55.6% of the health problems were resolved.


CONCLUSIONS
The elaboration of the NWP allowed to adapt the DA inverted exclamation mark der methodology at the hospital setting. The pilot plan was very useful in carrying out the pharmacotherapeutic follow-up of pediatric inpatients thus showing the necessity of pharmacistâs participation in the health team to improve the quality of the inpatientâs pharmacologic treatments.
Fontana Raspanti
D
D
Departamento de Farmacia. Facultad de Ciencias Químicas. Universidad Nacional de Córdoba. Argentina. danielaf@dqo.fcq.unc.edu.ar
Solá Uthurry
N
N
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring / Q000379:methods*; D004358:Drug Therapy / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D008297:Male; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D010865:Pilot Projects
Seguimiento farmacoterapéutico en pacientes pediátricos hospitalizados: adaptación de la metodología Dáder.